News
Novi, Michigan anticipates a $270M mixed-use development with housing, a hotel, and retail, needing public funding.
DES MOINES, Iowa — Des Moines is looking to improve safety for downtown travelers after approving its first rideshare hub in ...
Grifols (GRFS) secures a win in its defamation lawsuit against Gotham City Research in the U.S. Read more here.
NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentations of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of ...
Anyone driving in Downtown Buckeye knows changes are underway along Monroe Avenue. Last year, the city began Stage 1 of an ...
A start-up that launched only 8 months ago has attracted the attention of Biogen, a major developer of neurological drugs.
2d
Pharmaceutical Technology on MSNBiogen and City Therapeutics to develop RNAi therapyBiogen will pay City Therapeutics $46m, which includes $16m upfront and $30m investment for a convertible note.
Biogen Inc. (NASDAQ: BIIB )’s recent partnership with City Therapeutics, Inc. to develop RNAi therapies for central nervous ...
A development deal with Biogen Inc. could eventually bring City Therapeutics Inc. about $1 billion in milestone payments.
Healthcare companies rose as traders mulled the latest tariff headlines amid higher-than-expected May consumer confidence. Shares of Hologic advanced 15% after the Financial Times reported the company ...
Biogen ( NASDAQ: BIIB) and City Therapeutics signed a collaboration to develop novel RNA interference ( (RNAi)) therapies ...
Big Biotech Biogen is venturing into the city, paying $16 million in cash to partner up with an RNAi company to build ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results